ARCHIVES

Treatment Progress Increases Five Year Survival To 41%; Rates Compared For 10 Leading Cancers

This article is from The Cancer Letter archive.

Vol. 06 No. 17 | April 25, 1980

Download PDF Visit The Full Archive

Related Articles

Harvard’s Harvey Fineberg Is Elected IOM President.

November 16, 2001

IDMC Recommends Halting Phase III Trial Of Onartuzumab in MET-Positive NSCLC

March 28, 2014

NCI Shakeup Possibilities Grow; Marc Lippman To Head Lombardi Center; DCT Could Lose CTEP

March 11, 1988

Gore Proposes New War On cancer, Double research Funding Over 5 years

July 9, 1999

Stanford Group Working To Build ‘Superhighway’ To Synthesis Of Taxol

May 15, 1992

FDA Approves Tamoxifen For “Reduction In Incidence,” Avoids Word “Prevention”

November 6, 1998